Rasilez Hct (12.5/300 mg) Tablet

Manufactured by Novartis India Ltd
Composition: Hydrochlorothiazide (12.5 mg) + Aliskiren (300 mg)
Prescription Required: Yes


Rasilez Hct (12.5/300 mg) Tablet is a combination medicine used for the treatment of high blood pressure. Frequent monitoring of blood pressure and electrolytes level is necessary while taking this medicine. Patients are advised to follow a strict exercise and diet regimen along with this medicine to get the best possible effect.


Commonly asked questions for Rasilez Hct (12.5/300 mg) Tablet

Onset of action

The effect of this medicine can be observed within 2 to 4 hours of administration of the dose.

Duration of effect

The amount of time for which this medicine remains active in the body is not clinically established.

Safe with alcohol?


Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of serious adverse effects such as a very low blood pressure, fainting, dizziness, drowsiness, etc. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating heavy machinery if you consume alcohol during treatment with this medicine.

Is it habit forming?

No habit forming tendency has been reported.

Usage in pregnancy?

This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Usage while breast-feeding?

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.


We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.